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A bstract
O bjective : To te s t w h e th e r  fe r tility  in te n tio n s  d iffe red  
am o n g  p e rso n s  w h o  te s ted  p o sitiv e , tes ted  n eg a tiv e , or 
d id  n o t k n o w  th e ir  g en e tic  s ta tu s  fo r a m u ta tio n  o f th e  
B R C A 1  gene . M eth o d : P a rtic ip an ts  w ere  m em b ers  o f a 
la rg e  U tah -b ased  k in d re d  w ith  an  id e n tif ie d  m u ta tio n  
a t th e  B R C A 1  lo cu s . P a r tic ip a n ts  rece iv ed  g en e tic  
c o u n se lin g  p rio r  to  te s tin g  an d  w ere  in te rv ie w e d  at 
b a s e l in e  b e fo re  te s tin g  a n d  a t th r e e  p o in ts  a f te r  
rece iv in g  te s t re su lts  fro m  a g en e tic  co u n se lo r. T he  
sa m p le  in c lu d e d  m e n  an d  w o m en  w h o  co m p le ted  all 
in te rv iew s , w ere  b e tw e e n  ages 18 an d  45, an d  w ere  
fe rtile , re s u ltin g  in  a sa m p le  o f 101 re sp o n d e n ts . T he  
p rim a ry  d e p e n d e n t v a riab le  m easu red  w h e th e r  a s u b ­
jec t in d ica ted  th a t th e y  w ere  m o d e ra te ly  o r very  su re  at 
all th re e  p o s t-te s tin g  in te rv iew s  th a t th e y  in te n d e d  to  
h av e  a d d itio n a l ch ild ren . E ffects o f B R C A 1  m u ta tio n  
s ta tu s  on  fe r til i ty  in te n tio n s  w ere  e s tim a ted  u s in g  
m u ltiv a ria te  log istic  reg ress io n s  w h e re  w e co n tro lled
In troduction
Psychosocial s tu d ie s  on  the effects of p red ic tive  testing  
for cancer an d  o ther adu lt-o n se t d iseases have  largely  
focused o n  the ir psycholog ical im pact (e.g., d ep ressio n  or 
d istress) an d  on  in su rance  issues (1 -9 ). N o  system atic  
investiga tion  h as exam ined  how  ch ildbearing  in ten tions 
m ay  d iffer be tw een  rep ro d u c tiv e -ag ed  in d iv id u a ls  w ho 
have or do  n o t h av e  a genetic m u ta tio n  th a t confers a 
g rea ter suscep tib ility  to com m on d iseases su ch  as b reas t 
cancer.
In  the p re sen t s tu d y , w e exam ined  fertility  in ten tions 
re p o r te d  b y  a d u lts  of re p ro d u c tiv e  age  a fte r  th ey  
received  genetic test resu lts  for a m u ta tio n  of the B RC A 1  
gene. It is estim ated  th a t ~  5 -1 0 %  of b reas t cancer cases 
in  tlie genera l p o p u la tio n  are  associa ted  w ith  heritab le  
m u ta tio n s (10). W om en  w ho  ca rry  m u ta tio n s  in  the 
B R C A 1 /B R C A 2  genes have  a su b stan tia lly  increased  risk 
of d ev e lop ing  b reas t cancer an d  o v arian  cancer. In  1994, 
B R C A 1  w as the first m ajo r m u ta tio n  associa ted  w ith  
b reas t cancer to be  iden tified  a n d  fu lly  sequenced  (11).
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fo r g en d e r, age, m a rita l s ta tu s , an d  b a se lin e  fe r til ity  
in te n tio n s . R esu lts: F em ale  carrie rs  w ere  le ss  lik e ly  to  
w an t a d d it io n a l c h ild re n  in  re la tio n  to  fem ale  n o n ­
c a rr ie rs  (o d d s  ra t io  0.12, 95% c o n f id e n c e  in te rv a l 
0 .01-1 .23; P  = 0.074). N o d iffe ren ces  w ere  fo u n d  am o n g  
m en . T h ere  w as a  s ig n if ic a n t d iffe ren ce  in  th e  effect 
o f m u ta tio n  s ta tu s  on  fe r til ity  in te n tio n s  b e tw e e n  
m ales  an d  fem ales (G en d e r x  C a rrie r s ta tu s  in te rac tio n ; 
P  = 0.009). P ersons w h o  d id  n o t k n o w  th e ir  m u ta tio n  
s ta tu s  w ere  le ss  l ik e ly  to  w a n t m o re  c h ild re n  th a n  
n o n ca rr ie rs  (odds ra tio  0.09, 95% co n fid en ce  in te rv a l 
0 .01-0 .75; P  = 0.027). C o n c lu s io n : P red ic tiv e  genetic  
te s tin g  fo r la te -onse t cancer su scep tib ility  affects fam ily  
p la n n in g  d ec is io n -m ak in g . P ersons co n te m p la tin g  p re ­
d ic tiv e  te s tin g  s h o u ld  b e  in fo rm e d  a b o u t p o ss ib le  
effects su ch  te s tin g  m ay  h av e  on  th e ir  p la n s  fo r fu tu re  
fe r til ity . (C ancer E p id em io l B iom arkers P rev  2004; 
13(5):733 —40)
D ata d e riv ed  from  the B reast C ancer L inkage C on so r­
tiu m  ind ica ted  th a t the b reas t cancer risk  in  B RC A 1  
m u ta tio n  carriers is -8 5 %  b y  age 70 an d  the ovarian  
cancer risk  is 63% b y  age 70. A m ong  recru ited  fam ilies 
w ith  m u ltip le  m em bers affected  w ith  cancer, the lifetim e 
risks of b reas t cancer an d  ov arian  cancer for fem ale 
B R C A 1  carriers is 85% a n d  65%, respective ly  (12); h o w ­
ever, for m u ta tio n  carrie rs  from  a p o p u la tio n  from  
fam ilies n o t selected  for cancer fam ily  h is to ry , the risk  
is low er (13, 14). In  fam ilies th a t h ave  n o t b een  selected  
b ased  o n  fam ily  cancer h isto ry , B R C A 1  m u ta tio n  carriers 
have  average  cum ula tive  risks b y  age 70 of 65% for b reas t 
cancer an d  39% for ovarian  cancer (15). T here is also 
ev idence of an  increased  risk  of p ro s ta te  cancer in  B RC A 1  
m u ta tio n  carrie rs  (16). T herefore, genetic tes ting  for 
B R C A 1  m u ta tio n s is re levan t to m en  as w ell d u e  to  an  
increased  risk  of cancer a n d  because  m en  can  tran sm it 
the m u ta tio n  to the ir o ffspring. B R C A 1  m u ta tio n  carriers 
are  also a t excess risk  for cancers of the pancreas , u te rine  
b ody , a n d  cervix (16). A lth o u g h  fem ale carriers a re  at 
increased  risk  for cancer, b o th  m ale an d  fem ale carriers 
have  a 50% chance of tran sm ittin g  the a lte red  gene to 
each  offspring.
W ith  an  increased  risk  of cancer am o n g  m u ta tio n  car­
riers, p a rticu la rly  m o thers, p a ren ts  a n d  p rospective  p a ­
ren ts m ay  be  concerned  ab o u t the m o th e r 's  hea lth  an d  
m o rta lity  d u rin g  the ch ild  rearin g  years. A dd itionally , 
p a ren ts  m ay  be concerned  ab o u t tran sm ittin g  the in ­
c reased  risk  to  the ir ch ild ren . In  general, w e hy p o th es ized
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th a t m u ta tion  carriers w ou ld  be  less likely th an  no n ­
carriers to  rep o rt a desire  for ad d itiona l ch ild ren , and  
th is effect w ou ld  be  s tronger for w om en  th an  m en.
A  sm all lite ra tu re  exists th a t has exam ined  how  p re ­
d ictive tes ting  for noncancer d isease suscep tib ility  affects 
fam ily p lan n in g  am o n g  tested  persons. The find ings are  
lim ited an d  inconsisten t g iven th e  sm all sam ple  sizes 
and  th e  fact th a t fertility  questions a re  secondary  to  the 
specific a im s of th e  s tu d ies  (17). A  few  s tud ies  have 
considered  actual fertility  changes based  on genetic 
counseling  (18) o r perceived  o r know n genetic risks to  
a d u lts , g e n e ra lly  fo r ex trem ely  ra re  d isea se s  [e.£., 
sp inocerebellar ataxia (19), am yo troph ic  lateral sclerosis 
(20), an d  H u n tin g to n 's  d isease  (21, 22)]. In a s tu d y  of 
p ersons w ho  have been  tested  for B R C A 1 /B R C A 2  gene 
m u ta tions, L o d d er et a l  (23) asked  ind iv id u a ls  6 m on ths 
after receiv ing  th e ir te s t resu lts  w h eth er they  w ould  
consider te rm in a tin g  a p regnancy  if th e  fetus w as a 
carrier. The au th o rs  repo rted  th a t no carriers felt th a t 
en d in g  a p reg n an cy  w as acceptab le , w h ile  a sm all 
percen tage  (10-14% ) of noncarriers d id .
The p u rp o se  of th is article w as to  exam ine fertility 
in ten tions repo rted  b y  ad u lts  of rep ro d u c tiv e  age  after 
they  received genetic te s t resu lts  for a m u ta tion  of the 
B R C A 1  gene. To date , no stu d y  of genetic tes ting  for 
b re a s t cancer an d  ov arian  cancer su scep tib ility  has 
system atically  exam ined  th e  effects of genetic tes tin g  on 
fertility  in tentions.
M ateria ls  and M ethods
D ata for th is analysis w ere  based  on a large longitud inal 
stu d y  on th e  psychosocial and  behavioral consequences 
of B R C A 1  m u ta tion  testing. The m eth o d s of recru itm en t, 
e ligibility  criteria , and  protocol for th is  s tu d y  w ere 
described  in detail e lsew here  (24) b u t  sum m arized  here. 
S tudy  p a rtic ip an ts  w ere m em bers of a large U tah-based  
k indred  of no rth ern  E u ropean  descen t (K2082) w ith  an 
iden tified  m u ta tio n  a t  th e  B R C A 1  locus (25). All subjects 
in th e  s tu d y  a re  d escen d an ts  of a fo und ing  coup le  (four 
to  five genera tions earlier) know n to be  B R C A 1  m u ta tion  
carriers. The full sam p le  com prises 111 d is tinc t nuclear 
fam ilies.
M em bers w ere  first con tac ted  by  letter an d  inv ited  to  
partic ip a te  in a p ro spec tive  s tu d y  th a t offered in -person  
g en e tic /fam ily  counse ling  p rio r to  be in g  offered m u ta ­
tion  testing . In d iv id u a l genetic  co u n se lin g  w as also  
p ro v id ed  d u rin g  a session w hen  te s t resu lts  w ere p ro ­
v ided  to  subjects. Inv ita tion  letters w ere sen t to m em bers 
of th e  o ld es t genera tion  w ith in  a ped ig ree  follow ed by 
letters inv iting  th e ir a d u lt d escendan ts. To p ro tec t the 
p rivacy  of p a re n ts ' genetic in form ation , a d u lt offsp ring  of 
p a ren ts  w ho declined to  p artic ip a te  w ere  n o t them selves 
con tac ted  u n less  th e  p a re n ts  firs t p ro v id e d  w ritten  
consent. O nly  13% of these  p a ren ts  com pris ing  th e  o lder 
genera tion  (n = 152) declined  to  p a rtic ip a te  them selves 
and  less th an  half of those  p rec lu d ed  the  invo lvem en t of 
the ir a d u lt ch ild ren . K indred  m em bers w ho  expressed 
in terest w ere  contac ted  b y  p h o n e  an d  p ro v id ed  w ith  
m ore in fo rm ation , sen t a consen t form , an d  then  com ­
p le ted  a base line  in terv iew .
P artic ipa ting  k ind red  m em bers m e t in d iv idua lly  w ith  
a genetic counselo r to  d iscuss w h e th e r th ey  w ere  in ­
terested  in b e in g  tested . T he session inc luded  d iscussions 
ab o u t fam ily cancer h isto ry , m edical an d  cancer screen­
ing h isto ry , educational in form ation  ab o u t th e  B R C A 1  
m utation , and  associated  cancer risks. G enetic counselors 
a lso  exp lo red  th e  risks, benefits, an d  lim ita tions of 
testing . F urther de ta ils  of th e  counseling  issues associa t­
ed w ith  th is s tu d y  w ere  described  e lsew here  (26). If, after 
counseling , th e  in d iv idua l w ished  to  be  tested , a b lood 
sam p le  w as d raw n  an d  th e  tes t w as conducted . The 
in d iv id u a ls  th en  re tu rn e d  for an  in -p e rso n  genetic  
counseling  session to  d iscuss th e ir ind iv idua l results.
P artic ipan ts w ho  received th e ir te s t resu lts  w ere  con­
tacted  for the  first te lep h o n e  fo llow -up  in terv iew  1 -2  
w eeks after th e  receip t of th e ir te s t results. S ubsequen t 
te lep h o n e  in terv iew s w ere conduc ted  4 m on ths, 1 year, 
an d  2 years a fter the  receip t of te s t results.
C on tact letters an d  response  form s w ere  m ailed  to 
759 po ten tia l subjects. Five h u n d red  of these  in d iv idua ls  
received full in fo rm ation  ab o u t th e  pro jec t by  te lephone. 
Subjects w ho  did  n o t receive full pro ject inform ation  
(n = 259) d id  so because  they  refused  to  p artic ip a te  in 
th e  s tu d y  a t the  tim e  of th e  initial invita tion  to th e  stu d y  
(n = 124) o r p ro ject staff w ere  unab le  to  reach them  
(after repea ted  a ttem p ts) a fter th e  initial con tac t letter 
had  been  sen t (n = 135 of uncerta in  eligibility). O f th e  
759 subjects, 408 com pleted  th e  base line  questionna ire  
for a response  ra te  (type 1, w hich assum es all of 135 
uncerta in  eligibility  subjects w ere  indeed  eligible; h t t p : / /  
w w w .aap o r.o rg ) of 53.8%. For th e  500 subjects w ho 
received com plete  in fo rm ation  a b o u t th e  s tudy , 408 
com pleted  th e  base line  in terv iew  for a coopera tion  rate  
of 81.6%. U nfortunate ly , for m any of these  subjects, w e 
could  n o t confiden tly  m easu re  th e ir  ages because  they  
w ere  no t subjects in the  study . This m eans w e could  no t 
know  how  m any  po ten tia l subjects w ere  in o u r ta rg e t age 
g ro u p  of 18 -45 .
O f these  408 subjects, w e first restric ted  th e  sam ple  to 
those  w ho  w ere  of ch ildbearing  age (betw een  ages 18 
an d  45, n = 163). W e fu r th e r lim ited  th is su b sam p le  to 
re sp o n d en ts  w ho  w ere still ab le  to  have  ch ild ren  (n = 124) 
to  genera te  a pool of eligible p e rso n s  for th is analysis. In 
an  effort to  u n d e rs tan d  how  fertility  in ten tions changed  
over th e  2-year period  fo llow ing th e  receip t of m uta tion  
s ta tu s  in form ation , w e a lso  requ ired  th a t the  re sp o n d en t 
com plete  th e  4 -m onth , 1-year, and  2-year in terview s. 
T w en ty -th ree  p ersons of th e  124 initially  eligible subjects 
d ro p p ed  o u t of th e  s tu d y  by  th e  2-year in terv iew , leaving 
101 subjects th a t a re  th e  basis for th is  analysis. A ccord ­
ingly, th e  sam p le  com prises 81.5% (101 of 124) of th e  
eligible subjects iden tified  a t th e  tim e of the  base line  
in terv iew .
M easu res
Fertility Intentions/Behaviors. P artic ipan ts w ere  asked 
tw o  q u estio n s a b o u t th e ir  in ten tio n s to h ave  m ore  
ch ild ren  a t  base line  and  again  a t  th e  4 -m onth , 1-year, 
an d  2-year fo llow -up  in terv iew s. T he tw o  responses a t 
each tim e p o in t w ere  coded an d  com bined  to  crea te  a 
single d u m m y  variab le  rep resen tin g  th e  p a rtic ip an ts ' 
certa in ty  ab o u t th e ir fertility  in ten tions. The first question  
w as answ ered  in a yes (1) o r no (0) response: “ L ooking to 
th e  fu tu re , do  you (and y o u r w ife /h u sb a n d ) in tend  to 
have  a(no ther) child  som etim e?" The second question  
w as in a th ree -p o in t L ikert form at: “ H ow  su re  a re  you
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th a t you will have (m ore) ch ild ren?  A re you very su re , 
m odera te ly  su re , o r no t a t  all su re?"  A t each p o st-tes t 
in terv iew , these  tw o  variab les w ere  com bined to create  a 
single d icho tom y w here  in d iv id u a ls  w ho  w ere m o d er­
ately o r very su re  they  w an ted  a(no ther) child  w ere 
coded 1 an d  all o thers w ere  coded  0. H ereafter, these are  
called tim e-specific m easu res of fertility in ten tions. For 
18 h u sb an d s  of tested  w ives an d  14 w ives of tested  
h u sb an d s  from  the  sam p le  of 101 subjects, w e asked 
the sam e tw o  fertility  in ten tion  questio n s as w as asked 
of the  tested  ind iv id u a ls  a t  ~ 1-year post-test. A sim ilar 
d icho tom ous fertility  in ten tion  variab le  w as th en  con­
s tructed  for these  spouses.
A com posite  d e p e n d e n t variab le  w as also  constructed  
based  on  a su m m ary  of each sub jec t's  responses a t the 
th ree  m easu rem en t p o in ts  post-testing . In d iv id u a ls  w ho  
ind icated  th a t they  w ere  m odera te ly  or very su re  a t  all 
th ree  tim e p o in ts  th a t they  in tended  to  have  ad d itiona l 
ch ild ren  w ere coded  1 an d  all o thers  w ere  coded  0.
From  th e  2-year in terv iew , w e asked  subjects explicitly 
ab o u t th e ir connection  be tw een  th e ir genetic s ta tu s  and  
the ir fam ily p lan n in g  decisions based  on the fo llow ing 
question : "H av e  you changed  y o u r p lan s  ab o u t how  
m any ch ild ren  to  have because  you know  yo u r genetic 
s ta tu s? "  Subjects an sw erin g  " y e s "  w ere  coded 1 and  all 
o thers  w ere coded 0.
Social and Demographic Variables. G ender, n u m b er of 
existing  biological ch ild ren , educa tion  (years), m arital 
s ta tu s , an d  age (years) w ere  m easu red  d u rin g  th e  
baseline in terview .
Cancer H istory . All p a rtic ip an ts  w ere  asked  if they  
had  ever been  d iagnosed  w ith  cancer (breast, ovarian , 
p ro s ta te , a n d  lu n g ) o r  h ad  c a n ce r-re la ted  su rg e ry  
(oophorectom y, hysterectom y, and  m astectom y). A d d i­
tionally , all subjects w ere  asked  ab o u t th e  n u m b er of 
first-degree an d  second-degree  fem ale relatives w ho  had 
been  d iagnosed  by a physic ian  as hav ing  b reas t cancer 
a n d /o r  ovarian  cancer.
Test-Related Distress. The R evised Im p ac t of E vent Scale 
(IES; 27, 28) w as adm in is te red  to  p a rtic ip an ts  w ho  had 
b lood d raw n  to d e te rm ine  th e ir carrier sta tus. The IES is 
a 15-item scale th a t m easu res even t-re la ted  d is tress  and  
w as m odified  for th is  s tu d y  to assess d is tress  related  to  
p a rtic ip an ts ' rece ip t of th e ir genetic te s t result. In ternal 
consistency of th e  IES in th is  sam ple  w as h igh (Cron- 
b ach 's  a a  = 0.90). The m easure  used  in th is analysis w as 
taken  a t  the  4 m on ths p o st-te s t in terview .
Perceived R isk o f  Breast Cancer. A t baseline , w om en  
w ere asked  ab o u t th e ir perce ived  risk  of develop ing  
b reas t cancer based  on th e  fo llow ing question : "O n  
a scale from  0 to  100, w here  0 is no chance a t  all and  
100 is abso lu te ly  certa in , w h a t do  you th in k  are  the 
chances th a t you will g e t b rea s t cancer som etim e d u rin g  
y o u r life tim e ? "  A s im ila r  q u e s tio n  w a s  a sk ed  of 
w om en  reg a rd in g  perceived  ovarian  cancer risk. The 
tw o  perceived  risk  m easures w ere  h igh ly  correlated  
(r = 0.58, P  < 0.001) and  had  sim ilar effects on fertility 
in ten tions. O nly  th e  b rea s t cancer risk m easu re  w as 
considered  in th e  analysis.
B R C A 1 M u ta tio n  S ta tus. Subjects w ho  chose to  be 
tested  w ere  iden tified  a s  carriers o r noncarriers based  on 
b lood d raw n  for a D N A  test. The B R C A 1  m u ta tion  in th is
k in d re d  c re a te d  a s to p  c o d o n  a t  c o d o n  1313 on  
ch rom osom e 17q. The D N A  te s t w as a d irec t PCR tes t 
for th is  specific BR C A 1  m u ta tio n  pe rfo rm ed  by  the 
U n iversity  of U ta h 's  D N A  D iagnostic  L aboratory . For 
som e p a rtic ip an ts  w hose p a ren ts  o r g ran d p a ren ts  tested  
negative, they  m ay have learned  th a t they  w ere  n o n ­
carriers because  in d iv id u a ls  w ith  noncarrier ancestors 
are  also  noncarriers. Som e p a rtic ip an ts  chose to p a rtic ­
ipa te  in the  s tu d y  b u t chose n o t to  learn th e ir carrier 
sta tus. The final sam p le  inc luded  carriers (n = 25), 
noncarriers (n = 62), and  those  w ith  u n k n o w n  m uta tion  
s ta tu s  (UMS; n = 14).
S ta tis tica l M eth o d s . W e estim ated  th e  association  
be tw een  th e  receip t of B R C A 1  m u ta tion  s ta tu s  and  the 
in ten tions to  have  add itio n a l ch ild ren  by  m ultip le  logistic 
regressions. The p rim ary  d ep e n d e n t variab le  of in terest 
w as w h e th e r a re sp o n d en t sta ted  th a t they  w ere  m o d ­
erately  o r very su re  th a t they  w an ted  to have  add itiona l 
ch ild ren  a t  all th ree  in terv iew s (fertility com posite  v a r­
iable). In  an  a tte m p t to  illu stra te  th e  p a tte rn  of responses 
over tim e, w e estim ated  separa te  logistic regressions 
for fertility in ten tions a t  each of the th ree  tim e-specific 
in terv iew s. In these analyses, th e  d e p e n d e n t variable 
is coded  1 if subjects w ere  m odera te ly  o r very  su re  th a t 
they  w a n t ad d itiona l ch ild ren  as d e te rm ined  a t  the tim e 
of th a t p a rticu la r in terv iew . All o th er resp o n d en ts  w ere 
coded 0.
All m odels inc luded  in fo rm ation  on B R C A 1  m u ta tion  
s ta tu s  as m easu red  by  tw o  d u m m y  variables: carrier 
versus no n carrie r and  UM S versus noncarrier. O ther 
covariates inc luded  in the  m odel w ere  age, gen d er, and  
w h e th e r re sp o n d en ts  w ere  m odera te ly  or very su re  th a t 
they  w an ted  m ore children .
W e also exam ined  th e  effects of persona l and  fam ily 
cancer h isto ry , ed uca tion , n u m b er of biological ch ild ren , 
a n d , for th e  fem ale su bsam p le , perce ived  risk  of b reas t 
cancer. In  ad d itio n , w e explored  w h e th e r test-re la ted  
d is tress, as m easu red  by  th e  IES, m ig h t ac t as a m ed ia to r 
be tw een  receip t of m u ta tio n  tes ting  and  fertility  in ten ­
tions. N one of these  characteristics w ere found  to  be 
associated  w ith  fertility  in ten tions an d  th e ir inclusion  d id  
no t a lte r in any  su bstan tive  w ay  the effects of m uta tion  
s ta tu s  on fertility in tentions.
O u r analyses are  based  on m odels th a t inc luded  the 
b ase line  m easu re  of fertility  in ten tio n s b u t  n o t the 
n u m b er of ch ild ren  th e  p a rtic ip an ts  a lready  had . These 
tw o  m easu res  a re  h igh ly  correlated  (r = —0.57; those  w ith  
m ore ch ild ren  are  less likely to  w a n t ad d itiona l ch ild ren) 
a n d  in c lu d in g  b o th  m easu re s  in th e  m odel led to 
im precise  estim ates of b o th  of th e ir regression p a ra m e ­
ters. For th is reason , and  g iven th a t w e w ere  using  
fertility  in ten tions as o u r d ep e n d e n t variab le  an d  w e 
so u g h t to  contro l for such  in ten tions a t  base line , o u r final 
m odels contro lled  for base line  fertility  in ten tions b u t 
no t n u m b er of ch ild ren . W hen  w e inc luded  n u m b er of 
ch ild ren  b u t excluded  baseline fertility  in ten tions, the 
effects of B R C A 1  m u ta tio n  s ta tu s  on p o st-te s t fertility 
in ten tions w ere  n o t substan tive ly  altered .
T here w ere  m any instances w here  tw o  or m ore fam ily 
m em bers w ere  rep resen ted  in th e  sam ple , suggesting  
th a t th e ir fertility in ten tions w ere  co rrelated . G enera l­
ized estim ating  eq u a tio n s w ere  estim ated  u sin g  SAS 
PROC MIXED to assess w h eth er accoun ting  for co rre­
lated responses affected the  resu lts  (29). In general, the
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sim p ler regression  m odels th a t assum ed  in d ep en d e n t 
observations y ielded  resu lts  th a t w ere  prac tica lly  id en ­
tical to  those  u s in g  generalized  estim ating  equation . 
A ccordingly , resu lts  u s in g  s tan d a rd  logistic regressions 
a re  rep o rted  here.
Results
D em ographic  data  are  p resen ted  in Table 1. The sam ple 
of 101 inc luded  67 fem ales and  34 m ales. E ighteen 
h u sb a n d s  of te s ted  w iv es  an d  14 w iv es  of te s ted  
h u sb an d s  w ere  stu d ied  as a co m p lem en t to  the larger 
analysis of th e  full sam ple.
T he p ro p o r tio n  of su b jec ts  w h o  re p o r te d  b e in g  
m odera te ly  or v e ry  su re  th a t th ey  w an ted  add itional 
ch ild ren  is 59.4%, 47.5%, an d  41.6% a t th e  4-m onth ,
1-year, an d  2-year in terv iew s, respectively . N early  40% 
(39 of 101 or 38.6%) repo rted  w a n tin g  ad d itiona l ch ild ren  
a t all th ree  of th e  p o st-te s t in terv iew s of th e  sam ple. O f 
the rem ain in g  62 subjects, 60% (37 of 62) repo rted  th a t 
they  w ere  certa in  th a t th ey  d id  no t w a n t add itional 
ch ild ren  in each of the  th ree  p o st-tes ting  in terv iew s. 
A n o ther 22.5% (14 of 62) of th is su b se t of re sp o n d en ts  
ind icated  d u rin g  th e  4 -m onth  in terv iew  th a t th ey  w an ted  
m ore ch ild ren  b u t  then  repo rted  th a t th ey  w ere  su re  th a t 
they  had  com pleted  th e ir  ch ildbearing  a t bo th  1 -year and
2-year p o st-te s t in terv iew s.
The m ajority  of p a rtic ip an ts  (61.4%, 62 of 101) learned 
th a t th ey  d id  n o t ca rry  th e  B R C A 1  gene m u ta tion , 24.7% 
(25 of 102) learned  th a t th ey  w ere  carriers, an d  13.9% 
(14 of 101) chose no t to  learn  th e ir carrier s ta tu s  (the UMS 
group). The covariates th a t w e  exam ined  d id  n o t d iffer 
be tw een  these  th ree  g ro u p s  w ith  tw o  exceptions. C arriers 
w ere  m ore likely to  have a m o th er w ith  b re a s t cancer or 
ovarian  cancer (60%) follow ed b y  noncarriers (47%) and  
b y  th e  UM S g ro u p  (21%; x 2 = 5.37, d f  = 2; P = 0.068). 
T his p a tte rn  w as largely  d u e  to  d ifferences observed  
a m o n g  w om en  (x 2 = 9.5, d f  = 2; P = 0.009). A m ong  
carriers an d  noncarriers , m ean  IES scores a t the 4-m onth  
in terv iew  w ere  h ig h er for carriers (M  = 12.24 com pared  
w ith  M  = 6.74 for noncarriers; P = 0.019), a p a tte rn  
consisten t w ith  p rev io u s  s tud ies  on genetically  tested  
w om en  u sin g  these  data  (3).
In Table 2, w e  rep o rt the  resu lts  of a se t of tim e-specific 
lo g is tic  reg re ss io n s . E ach m odel a sse ssed  w h e th e r  
B R C A 1  m u ta tion  s ta tu s  affects fertility  in ten tions fo r a 
g iven p o st-te s t in terview . For reasons of p a rs im o n y  and  
g iven th e  re latively  sm all sam ple  size, all m odels initially  
inc luded  educa tion  level, persona l cancer h isto ry , fam ily 
cancer h isto ry , perce ived  cancer risk  a t  baseline, an d  IES 
score. G iven th e ir  w eak  association  w ith  fertility  in ten ­
tions, these  variab les w ere  excluded  from  th e  m odels. 
O n ly  those  key  variab les th a t exhibited  a sign ifican t 
re la tionsh ip  to  fertility  in ten tions (carrier sta tus, age, 
g ender, m arita l s ta tu s, and  base line  fertility  in ten tions)
Table 1. Descriptive statistics for the total sample and for BRCA1 mutation carriers, noncarriers, and UMS
Label Total Carriers Noncarriers Unknown
n Prop or SD n Prop or SD n Prop or SD n Prop or SD 
mean mean mean mean
BRCAl mutation carrier (=1) 101 0.248 0.434 25
UMS (=1) 101 0.139 0.347 25
No. biological children baseline 101 1.782 1.616 25
Certain w ant more 101 0.584 0.495 25
children baseline (=1)
Certain w ant more 101 0.594 0.494 25
children 4 months (=1)
Certain w ant more 101 0.475 0.502 25
children 1 year (=1)
Certain w ant more 101 0.416 0.495 25
children 2 years (=1)
Want more children all times 101 0.386 0.489 25
dichotomy (=1)
Alter fertility plans after test 101 0.069 0.255 25
result 2 years (=1)
Whether had a personal 101 0.03 0.171 25
history of cancer (=1)
No. first/second-degree female 101 1.564 1.337 25
relatives with BC/OC
No. first-degree female 101 0.634 0.902 25
relatives with BC/OC
Whether mother 101 0.465 0.501 25
had BC/OC (=1)
No. sisters had BC/OC 101 0.149 0.555 25
Age (years) 101 31.604 6.359 25
Female (=1) 101 0.663 0.475 25
Education (years) 101 14 1.817 25
Perceived breast cancer 67 48.94 23.23 18
risk baseline
IES 4 months 87 8.226 9.934 25
Married (=1) 101 0.822 0.385 25
Note: (=1), the variable is a dummy variable; BC/OC, breast cancer or
1 0 62 0 0 14 0 0
0 0 62 0 0 14 1 0
1.92 1.63 62 1.806 1.73 14 1.429 1.016
0.44 0.51 62 0.613 0.49 14 0.714 0.469
0.44 0.51 62 0.613 0.49 14 0.786 0.426
0.4 0.5 62 0.5 0.5 14 0.5 0.519
0.4 0.5 62 0.435 0.5 14 0.357 0.497
0.32 0.48 62 0.419 0.5 14 0.357 0.497
0.16 0.37 62 0.032 0.18 14 0.071 0.267
0 0 62 0.048 0.22 14 0 0
1.64 1.15 62 1.677 1.44 14 0.929 1.072
0.72 0.74 62 0.694 1.02 14 0.214 0.426
0.6 0.5 62 0.468 0.5 14 0.214 0.426
0.12 0.44 62 0.194 0.65 14 0 0
31.84 5.96 62 31.839 6.72 14 30.143 5.586
0.72 0.46 62 0.645 0.48 14 0.643 0.497
13.52 1.69 62 14.258 1.9 14 13.714 1.541
48.333 30.4 40 50.975 20.3 9 41.111 19.49
12.237 12.1 62 6.742 8.58
0.76 0.44 62 0.806 0.4 14 1 0
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Table 2. Effects of BRCA1 mutation status on fertility intentions at 4 months, 1 year, and 2 years post-test based 
on multiple logistic regressions
Variable
Main effects Main effects + interaction
Estimate P OR 95% CI Estimate P OR 95% CI
4 months
Intercept 7.41 0.0275 8.76 0.0182
UMS (=1) 0.49 0.687 1.64 0.15 18.11 0.44 0.7198 1.56 0.14 17.38
BRCA1 mutation carrier (=1) -0.79 0.3558 0.45 0.09 2.43 -0.32 0.7282 0.73 0.12 4.38
Age baseline -0.28 0.0037 0.75 0.62 0.91 -0.32 0.0032 0.72 0.58 0.90
Wants additional children baseline (=1) 2.49 0.0017 12.03 2.55 56.70 2.52 0.0023 12.42 2.45 62.93
Married (=1) 1.12 0.2764 3.06 0.41 22.93 1.26 0.2819 3.53 0.36 35.11
Female(=1) -0.40 0.6107 0.67 0.14 3.15 -0.83 0.3211 0.43 0.08 2.26
Female x BRCA1 mutation interaction -4.80 0.0253 0.01 <0.001 0.55
Model likelihood ratio (df) P 82.04 (6) <0.0001 87.58 (7) <0.0001
1 year
Intercept 6.1305 0.0308 6.8841 0.0218
UMS (=1) -1.2619 0.1338 0.283 0.054 1.474 -1.3361 0.1223 0.263 0.048 1.432
BRCA1 mutation carrier (=1) -0.0558 0.9426 0.946 0.207 4.318 0.312 0.7137 1.366 0.258 7.232
Age baseline -0.2945 0.0008 0.745 0.627 0.886 -0.3206 0.0008 0.726 0.602 0.876
Wants additional children baseline (=1) 1.601 0.0485 4.958 1.011 24.32 1.5519 0.0668 4.72 0.898 24.81
Married (=1) 2.2135 0.03 9.147 1.239 67.54 2.4667 0.0277 11.78 1.311 105.9
Female(=1) -0.8507 0.1871 0.427 0.121 1.512 -1.3145 0.0738 0.269 0.064 1.135
Female x BRCA1 mutation interaction -3.9485 0.0365 0.019 <0.001 0.78
Model likelihood ratio (df) P 67.07 (6) <0.0001 72.06 (7) <0.0001
2 years
Intercept 13.343 0.001 14.274 0.0008
UMS (=1) -2.1534 0.0259 0.116 0.017 0.772 -2.26 0.0245 0.104 0.015 0.748
BRC-A1 mutation carrier (=1) 0.4885 0.5977 1.63 0.266 10 1.0347 0.3153 2.814 0.373 21.21
Age baseline -0.533 <0.0001 0.587 0.453 0.76 -0.5666 <0.0001 0.567 0.431 0.748
Wants additional children baseline (=1) 0.5333 0.5807 1.705 0.257 11.31 0.5826 0.5697 1.791 0.24 13.35
Married (=1) 2.4821 0.0574 11.97 0.925 154.8 2.7519 0.0491 15.67 1.01 243.1
Female(=1) -2.0219 0.0128 0.132 0.027 0.651 -2.7123 0.0051 0.066 0.01 0.443
Female x BRCA1 mutation interaction -4.3056 0.0573 0.013 <0.001 1.144
Model likelihood ratio (df) P 80.67 (6) <0.000 84.76 (7) <0.0001
Note: (=1), the variable is a dummy variable.
w ere  u sed  as covariates in  th e  final m odels. F inally , w e 
re p o r t re su lts  th a t in c lu d ed  an  in te rac tio n  b e tw een  
gen d er an d  BRCA1  m u ta tio n  status. BRC A1  m u ta tio n  
s ta tu s  is rep resen ted  b y  tw o  d u m m y  variables: carrie r 
versus  n o n c a rr ie r  a n d  U M S versus  n o n ca rr ie r . T his 
in terac tion  is restric ted  to  th e  in terac tion  be tw een  gen d er 
a n d  the  d u m m y  variab le  “ carrier versus n o n ca rr ie r."  N o 
in terac tion  is in c lu d ed  be tw een  g en d er an d  "U M S versus 
n o n ca rr ie r"  d u e  the  sm all n u m b e r of subjects in  the  UMS 
group .
Table 2 show s a clear p a tte rn  of association  be tw een  
m u ta tio n  s ta tu s  a n d  fertility  in ten tions over tim e. First, 
th e  m ain  effect of b e in g  a  m u ta tio n  carrier versus a 
no n carrie r w as nonsign ifican t for each of th e  th ree  p o st­
te s t in te rv iew s. H o w ev er, w h en  w e in tro d u c e d  the 
in terac tion  te rm  be tw een  g en d er a n d  carrier sta tu s, w e 
found  th a t carriers w ere  significantly  less likely  to  rep o rt 
a d esire  for fu tu re  ch ild ren  th an  n o ncarrie rs  am o n g  
fem ales b u t  n o t m ales. For exam p le , 59% of m ale  
n o ncarrie rs  an d  86% of m ale  carriers w o u ld  like to  have  
ad d itio n a l ch ild ren  in  the  4 -m on th  in terv iew . A m ong  
w om en, the  p a tte rn  w as reversed  w ith  67% of n o n ­
carriers an d  28% of carriers rep o rtin g  a  p reference  for 
m ore  ch ild ren . T he re d u c tio n  in  fe rtility  in ten tio n s 
a m o n g  fem ale  c a rr ie rs  versus  n o n c a rr ie rs  (an d  an  
insign ifican t d ifference be tw een  m ale  carriers a n d  n o n ­
carriers) also  occurred  a t th e  1-year an d  2-year in te r­
view s.
Table 3 repo rts  resu lts  from  logistic reg ression  m odels 
th a t u sed  th e  com posite  d e p e n d e n t variab le  w here  w e 
com pared  perso n s w ho  h av e  rep o rted  w an tin g  a d d itio n ­
a l ch ild ren  a t a ll th ree  p o st-tes t in terv iew s w ith  everyone 
else. A gain , fem ale m u ta tio n  carriers, in  re la tion  to 
fem ale noncarriers , rep o rted  a sign ifican tly  low er in te rest 
in  h a v in g  a d d it io n a l c h ild re n  w h ile  th e re  w as an  
insign ifican t d ifference am o n g  m ales (G ender x  C arrier 
m u ta tio n ; P  -  0.01). W hen  th e  sam p le  w as restric ted  to 
w om en  (Fem ale-only sam p le  in  Table 3), w here  w e 
contro lled  for age, m arita l sta tu s, an d  base line  fertility  
in ten tions, fem ale carrie rs  w ere  less likely  to  w an t 
a d d itio n a l ch ild ren  [odds ra tio  (OR) 0.12, 95% confidence 
in te rva l (95% CI) 0 .01-1 .23; P  = 0.0744] in  re la tion  to 
n o n ca rr ie rs . N o  s ig n ific an t d iffe ren ces  w e re  fo u n d  
a m o n g  in  th e  m ale-spec ific  su b sam p le  (re su lts  n o t 
show n).
Table 3 a lso  show s th a t p ersons w ho  d o  n o t know  
their m u ta tio n  s ta tu s  h av e  significan tly  low er in ten tions 
to h av e  a d d itio n a l ch ild ren  th a n  n oncarrie rs  (OR 0.09, 
95% CI 0 .01-0 .75 ; P  = 0.027). This association  w as su g ­
gestive in  the tim e-specific m odels (Table 2) an d  becam e 
increasing ly  stronger w ith  th e  passage  of tim e an d  
finally  becom ing  sign ifican t b y  th e  2-year in terv iew  
(P  = 0.026).
By u s in g  th e  co m p o s ite  m e a s u re  th a t  co m p are s  
persons w ho  rep o rted  w an tin g  a d d itio n a l ch ild ren  a t 
all th ree  post-tes t in te rv iew s w ith  everyone else m ay
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Table 3. Effects o f BRCA1 m utation status on com posite fertility intentions based on multiple logistic regressions
Main effects Main effects + interaction Females only: main effects
Variable Estimate P OR 95% CI Estimate P OR 95% CI Estimate P OR 95% CI
Intercept 13.41 0.001 15.74 0.0012 11.24 0.0139
UMS (=1) -2.18 0.03 0.11 0.02 0.81 -2.45 0.0267 0.09 0.01 0.75 -2.9 0.0385 0.06 0.01 0.86
BRC-A1 mutation -0.42 0.65 0.66 0.11 3.96 0.25 0.8237 1.29 0.14 12.07 -2.13 0.0744 0.12 0.01 1.23
carrier (=1)
Age baseline -0.58 <0.0001 0.56 0.42 0.74 -0.67 0.0001 0.51 0.37 0.72 -0.52 0.0015 0.60 0.43 0.82
Wants additional 0.46 0.661 1.58 0.21 12.09 0.64 0.615 1.90 0.16 23.11 0.44 0.7482 1.56 0.1 23.81
children baseline (=1)
Married (=1) 3.49 0.015 32.62 1.97 539.60 4.02 0.0152 55.51 2.17 >999 3.22 0.0319 24.97 1.32 471.56
Fema!e(=1) -2.01 0.012 0.13 0.03 0.65 —3.23 0.0039 0.04 0.00 0.35
Female x BRCA1 -7.20 0.01 <0.001 <0.001 0.17
mutation interaction
Model likelihood 81.38 (6) <0.0001 90.80 (7) <0.0001 52.20 (5) <0.0001
ratio (df) P 
Note: (=1), the variable is a dummy variable.
o v e rlo o k  th e  p o ss ib ility  th a t  su b jec ts  ch an g e  th e ir  
m inds. W hen w e created  a new  tricho tom ous variab le  
th a t again  considers p references across all th ree  in te r­
v iew s (i.e., an  o rd inal variab le  w ith  th ree  categories: 
a lw ays w an ts  ch ild ren , varies be tw een  w an tin g  and  
no t w an tin g  ch ild ren , an d  never w an ts  ch ild ren ), w e 
used  an  o rd inal logistic regression  m odel. The resu lts 
y ie lded  nearly  identical conclusions as those  reported  
in Table 3.
F rom  th e  2-year in terv iew , w e exam ined  th e  associa­
tion betw een  m u ta tion  s ta tu s  a n d  w h eth er subjects m ade  
an exp lic it change in th e  n u m b er of ch ild ren  they  w ish  
to  have  because  of th e ir te s t result. W hile th e  p rev io u s 
m odels show  th a t a t least am o n g  fem ales, b e in g  a m u ­
tation  carrier w as associated  w ith  low er in ten tions to  
have ad d itiona l ch ild ren , th is  explic it question  ab o u t 
link ing  genetic  te s t resu lts  to  rep ro d u c tiv e  decis ion­
m ak ing  resu lted  in only seven affirm ative responses. 
N onetheless, th ere  is p re lim in a ry  su p p o r t in th is m odel 
th a t suggested  th a t carriers a re  5.46 tim es m ore likely 
(95% CI 0 .9 2 -3 2 .4 6 )  to  h a v e  a lte re d  th e i r  fam ily  
p lan n in g  m ore  th an  noncarriers because  of th e ir tes t 
resu lts  [i.e., 16% (4 of 25) a ltered  th e  n u m b er of ch ild ren  
they  w an ted  am o n g  carriers an d  3.2% (2 of 62) am o n g  
noncarriers; th e  P va lue  for the  age-sex ad ju s ted  d if­
ference is 0.0621; th e  ju s tifica tion  for a d ju s tin g  th e  
analysis for age an d  sex only  w as th a t th e  d ep e n d e n t 
variab le  is skew ed  w ith  very  few  p eo p le  rep o rtin g  
hav in g  m ad e  m ak ing  such  a change].
W e a lso  exam ined  fertility  in ten tions am o n g  the 
spouses of tes ted  in d iv id u a ls  (18 h u sb an d s , 14 wives). 
N o h u sb an d  w ith  a carrier w ife ind ica ted  a d esire  for 
ad d itiona l ch ild ren  (0 of 6), w hile  half of th e  h u sb an d s  
of noncarrie r w ives d id  (6 of 12; x 2 = 4.5, d f  = 1, 
F isher's  exact P = 0.054). O ne w ife o u t of th e  th ree  
carrie r h u sb a n d s  an d  27% of w ives of no n carrie r 
h u sb an d s  (3 of 11) w an ted  ad d itiona l ch ild ren  (x 2 =
0.024, d f  = 1, F isher's  exact P = 0.99). W hile w e w ere  no t 
able to  in terv iew  m ore spouses of rep ro d u c tiv e  age 
for th is  s tu d y , these  exp lo ra to ry  resu lts su g g est th a t 
th e  im p ac t of be ing  a fem ale carrier tran sla ted  in to  a 
reduc tion  in th e  h u sb a n d 's  fertility  in ten tions, b u t 
there  w as no  com parab le  effect am o n g  w ives of m ale 
carriers.
Discussion
W e exam ined  fertility  in ten tions am o n g  101 in d iv idua ls  
of rep ro d u c tiv e  age  from  a h igh -risk  k in d red  w ho  
p artic ip a ted  in a s tu d y  on genetic counseling  an d  testing  
for a BR C A 1  gene m uta tion . To o u r know ledge, no  s tu d y  
has system atically  exam ined  th e  fertility  in ten tions of 
in d iv id u a ls  receiv ing  genetic in fo rm ation  an d  testing  
for b reas t cancer an d  ovarian  cancer suscep tib ility . O u r 
resu lts  w ere  consisten t w ith  o u r hypo thes is th a t fem ale 
gene m u ta tio n  carriers w ere  less likely to  w an t add itiona l 
(or any) ch ild ren  com pared  w ith  fem ale noncarriers. W e 
found  no  effect of m u ta tion  s ta tu s  on fertility  in ten tions 
am o n g  m en.
In d iv id u a ls  w ho  chose n o t to  be  tested  and  w ho  d id  
n o t know  th e ir m u ta tion  s ta tu s  w ere  less likely to  w an t 
ad d itio n a l ch ild ren  than  noncarriers. It is n o t y e t clear 
w h a t m ay  m otivate  these  subjects to  lim it th e ir fam ily 
size. A p p a ren tly , th ese  in d iv id u a ls  w ere  especia lly  
anx ious a b o u t w h a t w ou ld  h ap p en  to  th em  shou ld  they  
learn th a t they  w ere  carriers, an  anx iety  th a t m ay  alter 
th e ir in ten tions to  have ad d itio n a l ch ild ren . H ow ever, 
w e w ere  unab le  to  iden tify  a characteristic  th a t clearly 
d ifferen tia ted  these ind iv id u a ls  from  those  w ho  chose 
to  be tes ted , in c lu d in g  p re te s tin g  assessm en ts of their 
likelihood of be ing  a m u ta tion  carrier or, as som e have 
suggested , dep ressio n  (4). G iven th e  po ten tia l im pact 
th a t genetic tes tin g  has on tested  p e rso n s an d  their 
spouses, w e exam ined  th e  quality  of th e  m arriag e  p rio r 
to  tes ting  an d  found  so m ew h a t m ore  m arita l stra in  
before  tes ting  am o n g  UM S in d iv id u a ls  in relation  to  
those  w ho  w ere  tested . C on tro lling  for p re te s t m arital 
stra in  d id  n o t m ed ia te  th e  association  betw een  n o t 
k now ing  o n e 's  m u ta tio n  s ta tu s  and  low er fertility  in ­
ten tions. M ore research  is justified  so th a t w e m ay better 
u n d e rs tan d  th e  m otives of in d iv id u a ls  from  h igh-risk  
fam ilies w ho  a re  offered tes ting  b u t choose to  forgo it.
The effects of th e  b u rg eo n in g  genetic technology  on 
rep ro d u c tiv e  issues have been  long been  a concern  of eth - 
icists an d  scho lars exam in ing  th e  eth ical, legal, an d  social 
im plications of genetics an d  genetic tes ting  (30 -32 ). The 
A m erican  Society of H u m an  G enetics, th e  N ational 
A dvisory  C ouncil for H u m an  G enom e R esearch, and  
th e  N ational B reast C ancer C oalition  have all called for
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a careful an d  con tinued  eva lua tion  of genetic tes ting  
before b ro ad e r clinical tes tin g  an d  po p u la tio n  screen ing  
is im p lem en ted . The speed  an d  success of the  H u m an  
G enom e Project h as certa in ly  he igh tened  questions ab o u t 
rep roduc tion  w ith  th e  a tte n d a n t increase in the  n u m b er 
of genetic tests for late-onset d iseases such  as those for 
m u ta tio n s  of th e  B R C A 1 /B R C A 2  genes. The increasing  
availab ility  of p red ic tive  genetic tes tin g  clearly  suggests a 
need for m ore  research  on its consequences for rep ro ­
ductive  decision-m aking .
It w as  su rp ris in g  th a t little w o rk  h a d  been  conduc ted  
reg a rd in g  the association  be tw een  p red ic tive  testing  and  
fertility  choices for tw o  reasons. F irst, th e  long -stand ing  
c o n c e rn s  a m o n g  e th ic is ts  a b o u t fe r til ity  o u tc o m e s  
am o n g  p e rso n s choosing  p red ic tive  tes tin g  w o u ld  su g ­
g est m ore  research  in th is a rena . Second, h igh -risk  
ind iv id u a ls  often ind ica ted  th a t th ey  chose tes tin g  to 
learn ab o u t cancer risks for th e ir ex is ting  ch ild ren 's  
b u t also for th e ir fu tu re  ch ild ren  an d  g randch ild ren , 
all w ith  an  eye to w ard  p rev en tio n , ea rly  detec tion , 
and  cu re  (33, 34). The m ajo rity  of resp o n d en ts  in o u r 
s tu d y  of K2082 also  repo rted  a m otiva tion  for be ing  
tested  w as  to learn ab o u t the cancer risks for their 
ch ild ren , realized  an d  po ten tia l.
O u r s tu d y  of fertility  in ten tions necessarily  focused 
on a sam p le  w h ere  fu tu re  fertility  w as  a possib ility . The 
sam ple  analyzed  h ere  w as  therefo re  restric ted  to  fertile 
m en  and  w om en . This stra teg y  h a d  som e im p o rtan t 
im p lica tio n s  for s tu d ie s  seek in g  to  u n d e rs ta n d  th e  
association  b e tw een  tes tin g  an d  fertility  in ten tions. W e 
h ave  repo rted  e lsew here  (35) th a t a fter testing , carrier 
w om en  w ere  sign ifican tly  m ore  likely to  h ave  b ilateral 
o o p h o rec to m ie s  th a n  n o n c a rr ie r  w o m en . T h is is a 
surgical p ro ced u re  th a t w as  p resen ted  as a possib le 
considera tion  in o u r s tu d y  protocol for fem ale carriers. 
W hile m ore  carrie r w om en  h ad  th e ir ovaries rem oved  
than  noncarrier w o m en , th e  m ajo rity  of rep roductive- 
aged  carriers d id  not h av e  oophorectom ies. This obser­
vation  suggests th a t m ore  concerned  carrier w om en  w ho  
w ere  fertile becam e su rg ica lly  sterile an d  hence w ere  no t 
asked  ab o u t th e ir fertility  in ten tions. It is p lausib le  th a t 
these sam e w o m en , p rio r to  th e ir su rgery , w o u ld  have  
s tro n g  view s ab o u t fu tu re  ch ildbearing  (tha t w ere  no t 
asked  a b o u t fu tu re  ch ild b ea rin g  because  th ey  w ere  
ste rile ). T h is scen a rio  su g g e s ts  th a t  th e  e s tim a te d  
association  repo rted  h ere  be tw een  fertility  in ten tions 
and  m u ta tio n  s ta tu s  a m o n g  w om en  m a y  be  conservative.
W e h ave  also  found  th a t carrier w om en  w ere  m ore 
likely th an  noncarrie r w o m en  to  h av e  h ad  oophorecto ­
m ies before th ey  learned  th a t th ey  w ere  carriers. Such an 
association  is explicable because  carrier w om en  have 
m ore  affected fem ale relatives, in fo rm ation  th a t p h y si­
cians m ay  use to base  the ir recom m endation  for a 
surgical in terven tion . This observation  too suggests th a t 
stu d ies  co n sidering  the fertility  effects of genetic tes ting  
am o n g  fer tile  w om en  m ay  be  b iased  because  som e of the 
h igh -risk  w om en  (m uta tion  carriers w h o  d o  no t ye t know  
th ey  are) w ill h ave  su rg ica lly  induced  sterility .
N o t all subjects w h o  w ere  in itia lly  inv ited  in to  the 
s tu d y  chose to  partic ipa te . W e know  th a t perso n s w ith  no 
o r few  affected close relatives a re  less likely to  partic ipa te  
(resu lts no t show n), a fea tu re  th a t suggests th a t no n ­
carriers are  less p ro n e  to  be  involved  in th e  s tudy . A c­
cord ing ly , w e  suggest th a t th is m ean s th a t o u r analysis
inc ludes th e  m ore  anx ious noncarriers , th ereb y  m ak in g  
th em  m ore  like m u ta tio n  carriers. This po ten tia l b ias  has 
the effect of m ak in g  o u r resu lts  conservative. G iven the 
long itud inal n a tu re  of o u r s tu d y , the sam p le  also  ex­
p erienced  a ttrition  over tim e. The loss of sam ple  size and  
the so m ew h a t g rea te r p ro p en s ity  of know n noncarriers to 
d ro p  o u t also  serve to  reduce  statistical p o w er an d  to  b ias 
ou r resu lts tow ard  the null. A gain , these m ethodolog ical 
issues serve to  m ake  o u r resu lts  conservative.
N early  all subjects in th is k ind red  w ere  iden tified  as 
p rac tic ing  m em b ers of the C h u rch  of Jesus C h ris t of 
L a tte r-day  Saints. A ccord ing ly , subjects ho ld  values th a t 
encourage  large fam ilies. Indeed , it w as  these values th a t 
facilitated  th is s tu d y  because  a p reference for m an y  
ch ild ren , on average , p ro v id ed  the o p p o rtu n ity  for u s  
to also  observe w id e  varia tions in fertility  in ten tions. The 
im pact of perce ived  genetic suscep tib ility  an d  fam ily  
cancer h is to ry  on fertility  in ten tions in  o ther pop u la tio n s 
m ay  also  be  sign ifican t because  these p o p u la tio n s  are 
m ore  likely to  h ave  preferences for sm aller fam ilies. For 
exam ple, in  a low er fertility  g ro u p  such  as A shkenazi 
Jew s w ith  a h ig h  risk for B RC A 1 / B R C A 2  m u ta tio n s, the 
effects m ig h t lead to  ch ild lessness. A ccord ing ly , the ef­
fects th a t m u ta tio n  tes ting  repo rted  h ere  are  likely to  be 
conservative  because  the p red isp o sitio n  of these  su b ­
jects w ill be  tow ard  p ro n a ta lism ' un like o th er p o p u la ­
tions w h ere  the desire  for ch ildbearing  m ig h t be  less 
firm ly  en trenched .
G enetic tes tin g  for b reas t cancer suscep tib ility  has 
largely  been  conducted  on  large at-risk  fam ilies. This 
ra ises a q u es tio n  a b o u t w h e th e r  these  fam ilies are  
rep resen ta tive  of fam ilies in th e  larger p o p u la tio n . A t 
p re se n t, re sea rch  fam ilies  h a v e  p ro v id e d  th e  o n ly  
long itud inal da ta  th a t can h e lp  u s  to  an tic ipate  the likely 
ou tcom es th a t m a y  occur w h en  larger-scale com m u n ity  
testing  occurs. G iven th a t en tire  fam ilies h av e  been 
inv ited  to  p artic ipa te  in these initial research  protocols, 
fam ily  m em b ers  w ere  able to  p ro v id e  su p p o r t to  each 
o ther a n d  likely d iscussed  the ir resu lts  w ith  one ano ther 
(36). In d iv id u a ls  co n tem p la tin g  tes tin g  o u ts id e  of a 
research  s tu d y  w ill be  less likely to  h av e  th e  sam e level 
of fam ily  su p p o r t an d  invo lvem en t of m edical research ­
ers w h en  com pared  w ith  research  fam ilies. For th is 
analysis, th e  effects of tes tin g  on fertility  in ten tions 
am o n g  m em bers of the K2082 k ind red  (as w ell as w ith  
o ther k ind reds enro lled  in  research  projects) m ay  differ 
from  th e  effects th a t arise  in th e  general com m unity .
This s tu d y  w as  based  on  a large k ind red  iden tified  
from  a com m on fo u n d er com pris ing  over 100 nuclear 
fam ilies s tu d ied  over a 2-year perio d  fo llow ing  testing. 
This w as  th e  first s tu d y  th a t h as  observed  long itud ina lly  
a large n u m b er of tested  ind iv id u a ls  a t risk  for a com m on 
late-onset cancer to d e te rm in e  how  genetic tes t resu lts 
affected fam ily  p lan n in g  decision-m aking . F u rth e r w ork  
is needed  to  d e te rm in e  w h e th e r reduced  fertility  in ten ­
tions tran sla te  in to  an  actual reduc tion  in  rep roduction .
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